The Day In Review: Acquisitions Help Biotech
10/19/2005 5:13:13 PM
More...
|
Jazz Pharmaceuticals, Inc. To Buy Orphan Medical, Inc. (ORPH) For About $122.6 Million In Cash
10/19/2005 5:13:08 PM
More...
|
Orphan Medical, Inc. (ORPH) Release: FDA Accepts Xyrem sNDA For Review, User Fee Deadline Set For November 18, 2005, Company Receives $1 Million Payment From UCB Pharma (UCBJF.PK)
10/19/2005 5:13:05 PM
More...
|
Orphan Medical, Inc. (ORPH) Announces Date Of 2005 First-Quarter Results Conference Call And Webcast
10/19/2005 5:13:02 PM
More...
|
Orphan Medical, Inc. (ORPH) Issues Xyrem Prescriptions Update
10/19/2005 5:12:49 PM
More...
|
Orphan Medical, Inc. (ORPH) Sees Lead Product Growing To $20 Million This Year
10/19/2005 5:12:49 PM
More...
|
Orphan Medical, Inc. (ORPH) Reports 2004 Results
10/19/2005 5:12:45 PM
More...
|
Orphan Medical, Inc. (ORPH) Announces Date Of Fourth-Quarter And Fiscal 2004 Results Conference Call
10/19/2005 5:12:38 PM
More...
|
Orphan Medical, Inc. (ORPH) Announces Patient Enrollment Is Complete In Clinical Trial Assessing Xyrem For The Treatment Of Fibromyalgia Syndrome
10/19/2005 5:12:29 PM
More...
|
Orphan Medical, Inc. (ORPH) Announces Fourth Quarter 2004 Xyrem Prescription Levels Up 9%; Expects 2005 Revenue To Exceed $35.0 Million
10/19/2005 5:12:27 PM
More...
|
|